Drawing for TURN-KEY

USPTO serial 79302618

TURN-KEY

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
—
Examiner
KENEALY, NATALIE LANGFORD
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TURN-KEY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JAMES R MENKER

James R Menker Holley & Menker, PAPO Box 331937Atlantic Beach, FL 32233UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business management consulting in relation to strategy, marketing, and production matters relating to discovering and identifying drug candidates; development of marketing strategies and concepts for others in the field of drug candidates; drug candidate market assessment services; business project management services for the biotechnology and pharmaceutical development sectorSECTION 70 - CANCELLED—
042Pharmaceutical research and development relating to discovering and identifying drug candidates; biomedical research services; medical research laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development of new products for others; research and development of medicines; scientific and technical consulting, research, and design services in the fields of pharmaceuticals, biopharmaceuticals, nanotechnology, drug delivery systems, drug carriers, drug delivery apparatus, and clinical studies and trials; scientific project management services for the biotechnology and pharmaceutical sectorSECTION 70 - CANCELLED—
045Consultancy relating to the licensing of intellectual propertySECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 23, 2025DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
May 23, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 29, 2025FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 7, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 7, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 18, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 6, 2024MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Mar 1, 2024ABN3ABANDONMENT - AFTER EX PARTE APPEAL—
Mar 1, 2024EXPTEXPARTE APPEAL TERMINATED—
Jan 19, 2024EXFBEXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF—
Nov 8, 2023GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Nov 8, 2023GECDACTION DENYING REQ FOR RECON E-MAILED—
Nov 8, 2023CNCFACTION CONTINUING FINAL - COMPLETED—
Sep 21, 2023DOCKASSIGNED TO EXAMINER—
Mar 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 6, 2023EXPIEX PARTE APPEAL-INSTITUTED—
Mar 6, 2023JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Mar 6, 2023EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Sep 19, 2022GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Sep 19, 2022GNSFSUBSEQUENT FINAL EMAILED—
Sep 19, 2022CFRCSUBSEQUENT FINAL REFUSAL WRITTEN—
Aug 18, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 18, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 18, 2022ALIEASSIGNED TO LIE—
Jul 23, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jul 11, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 22, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 22, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 5, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 5, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Apr 5, 2022CNSLSUSPENSION LETTER WRITTEN—
Mar 15, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 14, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 14, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 14, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 14, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 14, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 9, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 8, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2021RFNTREFUSAL PROCESSED BY IB—
Feb 8, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 8, 2021RFRRREFUSAL PROCESSED BY MPU—
Jan 29, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 28, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 22, 2021DOCKASSIGNED TO EXAMINER—
Jan 22, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 21, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance